Allergy and Clinical Immunology
Education and Training Programs at 天美传媒l
Welcome to the Allergy and Immunology Fellowship Program at Brigham and Women’s Hospital, a teaching affiliate of Harvard Medical School. Our mission is to train the next generation of academic leaders and physician-scientists addressing the diagnosis, treatment, and prevention of allergic and immune-mediated disease. We advance the career development of our fellows through outstanding clinical and educational programs, our diverse and highly collaborative research environment, team mentoring, and strong institutional support. Our program has made pioneering advancements in Allergy and Immunology for more than 50 years.
We are proud of the success of our graduates, who include more than 90 full Professors, four past Presidents of the American Academy of Allergy, Asthma and Immunology, and many prominent young faculty around the country. Over 75% of our graduates in the past ten years hold full-time faculty positions at US Medical Schools, most of whom are actively engaged in research. We look forward to continuing this tradition and developing the next generation of innovators in science and medicine.
We accept outstanding residents who have completed training in either Pediatrics or Medicine into our ACGME-accredited program. The first 12 months are focused on clinical training across the inpatient and outpatient settings and include rotations through our Severe Asthma Program, Mastocytosis Center, Drug Hypersensitivity and Desensitization Center, Immunodeficiency Clinic, and Aspirin-Exacerbated Respiratory Disease (AERD) Center. Fellows will manage patients with a wide spectrum of disorders including primary immunodeficiencies, autoimmune disorders, hereditary angioedema, anaphylaxis, food allergy, eosinophilic disease, drug allergy, asthma, and mastocytosis.
In transitioning to the research component (supported for 2-3 years by a National Institute of Health Training Grant), fellows can pursue a broad variety of approaches including cellular and molecular immunology, genomics and metabolomics, clinical epidemiology and population science, bioinformatics, and clinical trials. See the Current Fellows to find out how our trainees are taking advantage of the unparalleled research and training opportunities available in the Longwood Academic and Medical area, home to leading institutions such as Harvard Medical School, Channing Division of Network Medicine, Harvard T.H. Chan School of Public Health, and Dana Farber Cancer Institute, in addition to Brigham and Women’s Hospital.

Our mission is to train the next generation of physician-scientists spanning a broad range of approaches. Through a National Institute of Health-funded training grant and additional institutional funding, we fully support fellow research for up to three years.

Our clinical training emphasizes evidence-based medicine, the achievements and limitations of current immune-modulating therapies, and the biological insights to be gained by applying cutting-edge science to clinical disease. Our approach to developing the next generation of academic leaders begins in the first year.

Chief, Allergy/Immunology

Program Director, Allergy/Immunology Fellowship

Associate Program Director, Allergy/Immunology Fellowship
, Brigham and Women’s Hospital, Allergy and Immunology
The generates evidence on the Utilization, Safety, and Effectiveness (USE) of biologic therapies approved for the treatment of asthma and other allergic/immunologic diseases
, Boston Children's Hospital, Genetics.
The studies mechanisms that maintain genomic stability in mammalian cells. The programmed recombination and hypermutation events in lymphocytes and the general DNA repair mechanisms involved in these processes are a focus.
Brigham and Women’s Hospital, Allergy Immunology
The is interested in defining the innate cellular and molecular networks underlying the initiation and persistence of type 2 immunity at mucosal sites.
Brigham and Women’s Hospital, Allergy Immunology
Dr. Bankova focuses on the control of epithelial barrier function by mast cells and their products.
Brigham and Women’s Hospital, Allergy Immunology
The Boyce lab is focused on cross-talk between eicosanoid receptor systems in pulmonary inflammation, using a combination of cellular, molecular, whole animal, and human translational approaches.
Brigham and Women’s Hospital, Allergy Immunology
Dr. Brennan focuses on the role of innate-like T cells in allergic disease and host defense.
Brigham and Women’s Hospital, Rheumatology
The Brenner laboratory works on lipid and glycolipid antigens recognized in the context of CD1 antigen-presenting molecules, T cell recognition, and inflammatory arthritis.
, Brigham and Women’s Hospital, Pathology
Lynn Bry is a physician, anaerobic microbiologist, and microbial geneticist at Brigham & Women's Hospital, and Harvard Medical School.
Dr. Buchheit’s research continues to be focused on understanding AERD and nasal polyposis, and she is dedicated to investigating the causative mechanisms and exploring new treatments for these diseases.
, Massachusetts General Hospital, Emergency Medicine
Dr. Camargo’s research primarily focuses on respiratory and allergy disorders, including asthma and anaphylaxis, as well as the effects of vitamin D and health services research within emergency departments.
, Harvard Medical School, Immunology
The central goal of the is to understand the role of neuroimmune interactions in pain, itch, and tissue immunity.
Brigham and Women’s Hospital, Rheumatology, Clinical Sciences
Dr. Costenbader’s research focuses on epidemiologic risk factors for systemic lupus erythematosus (SLE) and for rheumatoid arthritis (RA) and outcomes among patients with autoimmune disease.
, Brigham and Women’s Hospital, Allergy and Immunology
The focuses on determining the signals that recruit mast cell progenitors from the circulation to inflamed tissues, understanding how mast cells integrate tissue- and inflammation-associated signals to take on a range of discrete phenotypes, and discovering how these phenotypes influence both tissue homeostasis and disease progression.
, Brigham and Women’s Hospital, Allergy and Immunology
Dr. Foer’s work focuses on the role of the glucagon like peptide receptor-1 pathway in metabolic homeostasis and platelet-driven airway inflammation in asthmatic patients with type 2 diabetes.
Dana Farber Cancer Institute, Medical Oncology
The is interested in defining the dynamic interactions between the mucosal immune system and gut microbiota.
, Boston Children's Hospital, Pediatrics
The focuses on the molecular basis and mechanisms of (1) primary immune deficiency diseases and (2) atopic dermatitis.
, Boston Children's Hospital, Pediatrics
in Systems Immunology and Regulatory Genomics investigates the molecular mechanisms of immune-mediated diseases.
Brigham and Women’s Hospital, Pulmonary
Dr. Israel’s major research interests include mediators of airway reactivity, the role of arachidonic acid metabolites in airway narrowing, and genetic influences in asthma pharmacotherapeutics, particularly as they relate to responses to beta-agonists.
Brigham and Women’s Hospital, Rheumatology, Clinical Sciences
Dr. Karlson’s research focuses on the environmental risk factors for SLE and RA, and the causes of long-term complications of these diseases, such as atherosclerosis, and their prevention.
Brigham and Women’s Hospital, Allergy Immunology
Dr. Laidlaw Directs Translational Research in Allergy and the (AERD) Center at BWH. She combines clinical interventions with benchside approaches to understand the pathogenetic basis of AERD. The is focused on translational research approaches to studying human respiratory inflammation, sinus disease, and aspirin/NSAID hypersensitivity.
Dr. Lasky- Su has focused on the analysis of genetics, genomics, and metabolomics data of various complex diseases with a primary focus on asthma over the last 15 years.
Brigham and Women’s Hospital, Pulmonary
The focuses on bioactive lipid mediators that regulate inflammation.
Brigham and Women’s Hospital, Rheumatology
The studies the molecular and in vivo mechanisms by which CD1 and lipids activate T cells during allergy, autoimmune and infection.
Brigham and Women’s Hospital, Allergy and Immunology
Dr. Nagai focuses on the molecular mechanisms involved in cysteinyl leukotriene receptor and purinergic receptor signaling pathways, and their role in the pathophysiology of type 2 immunopathology in the airway.
, Boston Children's Hospital, Pediatrics
studies IgE and mast cell functions in the regulation of allergic sensitization and in the pathogenesis of food allergy.
, Massachusetts General Hospital, Allergy and Immunology
at Massachusetts General Hospital is focused on the study of allergen-specific antibodies in allergic diseases.
, Boston Children's Hospital, Pediatrics
is focused on clinical research for pediatric asthma and allergic diseases.
, Harvard Medical School, Med/Health Sciences
explores the contributions of B cells to the development and function of T follicular helper cells and cytotoxic CD4+ T cells.
, MD, CM
Dr. Benjamin Raby serves as the Director of the BWH Pulmonary Genetics Center, where he and his clinical team evaluate and care for patients with genetic forms of lung disease and provide counseling and diagnostic services to their at-risk relatives.
Brigham and Women’s Hospital, Rheumatology
Dr. Raychaudhuri is a pioneer of integrative technologies that allows genetic data to be interpreted in the context of functional genomic data.
, Brigham and Women’s Hospital, Renal
is interested in understanding how follicular T cell subsets such as Tfh and Tfr cells regulate B cell responses.
, Massachusetts General Hospital, Allergy and Immunology
The Shreffler Lab at Mass General studies the mechanisms regulating primary sensitization and the subsequent balance between immune progression or regulation that determines either clinical sensitivity or tolerance to mucosal allergens.
, Brigham and Women’s Hospital, Pulmonary
The mission of the is to leverage these mechanisms to develop new therapies to improve the health of patients with chronic diseases by restoring this reparative capacity of the airway epithelium.
Channing Division of Network Medicine
Dr. Weiss focuses on the genetics/epidemiology of asthma and complex diseases, pharmacogenetics/genomics, and bioinformatics.
Brigham and Women’s Hospital, Allergy Immunology
The studies the process of primary immunoglobulin repertoire diversification and how environmental factors, such as commensal microbes and diet, may influence the structure and depth of this diversity. The lab is particularly interested in how exposures early in life may shape this process.
For the most up-to-date listing, please see the following PDF.
For the most up-to-date listing, please see the following PDF.
For the most up-to-date listing, please see the following PDF.
Brigham and Women’s Hospital is located in the Longwood Medical Area, home to a thriving academic community with Harvard Medical School, Boston Children’s Hospital, the Channing Division of Network Medicine, and the T. H. Chan Harvard School of Public Health. Surrounded by the communities of the South End, Jamaica Plain, and Brookline, the area offers many safe and green places for young people to live in close proximity to work. While the greater Boston and Cambridge area is known for biotechnology and healthcare, Boston boasts many other cultural attractions. Here are a few helpful links to the great City of Boston:
Outdoor activities
Art, Music, and Nightlife
Sports
Joanne Miccile
Program Contact
60 Fenwood Road, Boston, MA 02115
Phone: 617-525-1302
Fax: 617-525-1310
Email: jmiccile@rics.bwh.harvard.edu
David Hong, MD
Director, Allergy Immunology Fellowship
60 Fenwood Road, Boston, MA 02115
Phone: 617-525-1232
Fax: 617-525-1310
Email: dhong@bwh.harvard.edu
For over a century, a leader in patient care, medical education and research, with expertise in virtually every specialty of medicine and surgery.
About BWH